- The trend backdrop is active with a 13-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
BALAMINES
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Balaji Amines Limited · Basic Materials · Specialty Chemicals
Latest close
2,030 INR
-4.9%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 31.9% above the Trend Line and sits at 71.9% of its 52-week range. The latest completed week returned -4.9%, after a -16.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
53
out of 100
Latest Close
2,030 INR
7 Aug 2026
1W Return
-4.9%
latest completed week
4W Return
-16.0%
short-term follow-through
12W Return
19.5%
quarterly tape
Trend Breadth
38.5%
20 of 52 weeks active
Volume Ratio
0.8x
vs 13-week average
- Next-week expectancy is negative at 38.53% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-4.9%
Latest completed week; four-week move -16.0%.
Indicator stack
66/60
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 38.53%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
37 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 31.9% above the Trend Line and sits at 71.9% of its 52-week range. The latest completed week returned -4.9%, after a -16.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9612-week average 0.75
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.96Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -16.0% over four weeks, 19.5% over 12 weeks, and 32.3% over one year. The current trend has remained active for 13 consecutive weeks.
Performance by holding period
Active trend streak13 weeks
Active weeks in one year20
Trend breadth38.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.77Latest activity-pressure read.
Pressure change-49.0%Four-week change in activity pressure.
Leadership40.54Latest relative-leadership reading.
RS change-45.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength23/100Blend of value, momentum, and quality. Underlying universe rank 78; rank 1 is best.
Value22/100Relative valuation strength. Underlying universe rank 79; rank 1 is best.
Quality22/100Profitability and accounting quality. Underlying universe rank 79; rank 1 is best.
Momentum88/100Medium-term price momentum. Underlying universe rank 13; rank 1 is best.
Growth21/100Revenue and earnings growth. Underlying universe rank 80; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework24/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 39.3x Price divided by trailing earnings.
- Price / sales
- 4.6x Market value relative to trailing revenue.
- EV / EBITDA
- 23.1x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -5.2% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 43.7% Gross profit retained from each unit of revenue.
- Operating margin
- 14.7% Operating profit retained from revenue.
- Free-cash-flow margin
- -25.0% Free cash flow generated from revenue.
- Return on invested capital
- 7.7% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 1.0% Latest one-year revenue growth.
- EPS growth
- 6.1% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -833.1% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.5% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.5% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 37 relevant articles.
5 positive · 28 neutral · 4 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-16.9%Distance below the 52-week high.
13-week volatility7.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+15.1%Week of 5 Jun.
Worst week-7.0%Week of 26 Jun.
Latest week-4.9%Week of 7 Aug.
Shape of recent returns
Strong gains11
Modest gains4
Flat weeks0
Modest losses5
Sharp losses6
Recent vol7.7%13-week weekly-return volatility.
Base vol5.8%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew5.2% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank- / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Specialty Chemicals
4-week rank99 / 100
Group average5.8%
Trend breadth77.0%
Trend77.0%active weekly trend signals
MD75.0%positive activity pressure
RS72.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape58/100
Trend, activity pressure, participation, and risk combine to a 58/100 tape read.
Indicator analysis91/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.96; No reversal markers Next-Week ExpectancyNegative 38.53%Next-week expectancy is negative with a 38.53% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors36/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 25; Small Cap Core rank 72 SVQF24/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1199.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 37 relevant articles.
Balaji Amines - 10 smallcap stocks soar up to 230% this year, 3 turn multibaggers. Do you own any? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 2,030 INR | -4.9% | 1,539 INR | 1,797 INR | 0.77 | 40.54 | 1.2M | On |
| 31 Jul 2026 | 2,133 INR | -1.9% | 1,510 INR | 1,798 INR | 1.20 | 49.81 | 1.9M | On |
| 24 Jul 2026 | 2,174 INR | -5.0% | 1,476 INR | 1,799 INR | 1.36 | 57.63 | 952.2K | On |
| 17 Jul 2026 | 2,289 INR | -5.2% | 1,441 INR | 1,799 INR | 1.42 | 63.38 | 959.2K | On |
| 10 Jul 2026 | 2,415 INR | 10.1% | 1,402 INR | 1,798 INR | 1.50 | 74.67 | 3.6M | On |
| 3 Jul 2026 | 2,194 INR | 10.9% | 1,359 INR | 1,797 INR | 1.46 | 59.84 | 162.9K | On |
| 26 Jun 2026 | 1,979 INR | -7.0% | 1,323 INR | 1,797 INR | 1.55 | 46.47 | 0 | On |
| 19 Jun 2026 | 2,128 INR | 0.2% | 1,295 INR | 1,799 INR | 1.70 | 58.44 | 152.6K | On |
| 12 Jun 2026 | 2,122 INR | 4.4% | 1,264 INR | 1,800 INR | 1.82 | 62.55 | 212.3K | On |
| 5 Jun 2026 | 2,033 INR | 15.1% | 1,234 INR | 1,801 INR | 1.91 | 59.16 | 528.9K | On |
| 29 May 2026 | 1,767 INR | -2.6% | 1,213 INR | 1,801 INR | 1.98 | 38.62 | 1.2M | On |
| 22 May 2026 | 1,814 INR | 6.8% | 1,201 INR | 1,803 INR | 2.00 | 42.10 | 3.1M | On |
| 15 May 2026 | 1,698 INR | 14.7% | 1,187 INR | 1,805 INR | 1.93 | 34.35 | 4.9M | On |
| 8 May 2026 | 1,480 INR | 11.5% | 1,176 INR | 1,809 INR | 1.72 | 15.19 | 1.5M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.